Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Hologic (HOLX) to Report Q3 Earnings: What's in the Cards?
03:30pm, Friday, 15'th Jul 2022 Zacks Investment Research
Hologic's (HOLX) Q3 results will likely gain from the continued uptake of its Panther instruments and an ongoing rebound in elective procedures.
Ultragenyx (RARE) Sells Portion of Royalty Interest for $500M
01:47pm, Friday, 15'th Jul 2022 Zacks Investment Research
Ultragenyx (RARE) sells 30% of the royalty interest receivable on future North America sales of Crysvita for $500 million. The total payments are capped at 1.45 times the purchase price.
This New Regulation Could Juice Pfizer Stock Even More
12:55pm, Friday, 15'th Jul 2022 The Motley Fool
Pharmacists will be able to prescribe Paxlovid now.
J&J (JNJ) to Begin Pharma Sector's Q2 Earnings With a Beat?
12:17pm, Friday, 15'th Jul 2022 Zacks Investment Research
J&J's (JNJ) Pharma segment is expected to have performed above the market. In the MedTech segment, the recovery in demand trends seen in the first quarter is likely to have continued in the second.
Pharma Stock Roundup: MRK Buys Cancer Drug Rights, SNY Dupixent Kids Study Succeeds
11:48am, Friday, 15'th Jul 2022 Zacks Investment Research
Merck (MRK) buys co-development rights to prostate cancer candidate. FDA grants full approval to Pfizer's (PFE) COVID-19 vaccine for adolescents.
How Tax Loss Harvesting Works -- Turn Lemons Into Lemonade
11:00am, Friday, 15'th Jul 2022 The Motley Fool
Here's an investment strategy that allows you to purge losers without tax ramifications.
Best Growth Stocks to Buy for July 15th
09:54am, Friday, 15'th Jul 2022 Zacks Investment Research
: DLTR, LNTH and MRK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 15, 2022.
Best Growth Stocks to Buy for July 15th
08:19am, Friday, 15'th Jul 2022
: DLTR, LNTH and MRK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 15, 2022.
Best Income Stocks to Buy for July 15th
07:23am, Friday, 15'th Jul 2022 Zacks Investment Research
IBCP, PBR, and MRK made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 15, 2022.
Best Income Stocks to Buy for July 15th
05:16am, Friday, 15'th Jul 2022
IBCP, PBR, and MRK made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 15, 2022.
Vaxcyte (PCVX) Completes Enrollment in Pneumococcal Disease Study
03:59pm, Thursday, 14'th Jul 2022 Zacks Investment Research
Vaxcyte (PCVX) enrolls the last patient in the phase II portion of phase I/HH study, evaluating VAX-24 for preventing invasive pneumococcal disease and pneumonia in healthy adults.
Here's Why Investors Should Retain Phibro (PAHC) For Now
03:46pm, Thursday, 14'th Jul 2022 Zacks Investment Research
Investors are optimistic about Phibro's (PAHC) major animal health products and robust vaccine sales.
LabCorp (LH) Debuts NfL Test for Neuronal Damage Diagnosis
03:42pm, Thursday, 14'th Jul 2022 Zacks Investment Research
LabCorp's (LH) widely accessible NfL blood test presents direct evidence of neuronal injury resulting from brain injury or diseases like Alzheimer's, among others.
Merck (MRK) Buys Rights to Mid-Stage Prostate Cancer Candidate
02:46pm, Thursday, 14'th Jul 2022 Zacks Investment Research
Merck (MRK) is set to make an upfront payment of $290 million to Orion for co-development and co-commercialization rights to ODM-208.
What's in Store for Abbott Laboratories (ABT) in Q2 Earnings?
02:33pm, Thursday, 14'th Jul 2022 Zacks Investment Research
Excluding COVID testing sales, Abbott's (ABT) worldwide Diagnostic sales are expected to have demonstrated strong growth in Q2 on the continuous rollout of Alinity.
